AC
Insider
Andrew Callos
EVP, Chief Commercial OfficerAndrew Callos (EVP, Chief Commercial Officer) filed 18 Form 4 reports in the trailing twelve months (0 purchases, 18 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $3.5M of CYTK (52,486 sh × $65.95, as filed), executed Dec 5 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
18
0 buys · 18 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$15.7M
shares × price, as filed
Last traded
Aug 31
Filed Aug 31
Median ADV $207.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $18.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
18 filings
Sector per market data · by filing · past 12 months
Most traded names
CYTKRecent filings
CYTKSALE
Cytokinetics, Incorporated
View filing →
$145K3,341 sh × $43.27
Exec Mar 6 2025
Filed Mar 7 2025 · 5:30 PM ET